Log in or Sign up for Free to view tailored content for your specialty!
Neurorehabilitation News
SemontPlus maneuver more effective than Epley maneuver for vertigo
BOSTON — The SemontPlus maneuver led to quicker recovery than the Epley maneuver in patients with posterior canal benign paroxysmal positional vertigo, according to research presented at the American Academy of Neurology annual meeting.
Catheter ablation improved cognitive outcomes in older adults with atrial fibrillation
BOSTON — Older adults with atrial fibrillation who underwent catheter ablation developed less cognitive impairment than those receiving only medical management, according to a presenter at the American Academy of Neurology annual meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Mild cognitive impairment is underdiagnosed in US Medicare population
BOSTON — Now that there are disease-modifying treatments for Alzheimer’s disease, the necessity of identifying “contemporary population-level diagnosis rates of mild cognitive impairment and dementia” is crucial, according to a presenter.
Lumevoq demonstrates sustained improvement of BCVA up to 5 years in LHON
BOSTON — Results from the long-term RESTORE study show patients with Leber hereditary optic neuropathy with ND4 mutation who were treated with Lumevoq had sustained improvement of best-corrected visual acuity in both eyes.
Laser interstitial thermal therapy may offer seizure freedom in drug-resistant epilepsy
BOSTON — Laser interstitial thermal therapy may offer seizure freedom to select patients, particularly those with drug-resistant temporal lobe epilepsy, according to a poster at the American Academy of Neurology annual meeting.
Eculizumab effective in adolescents with refractory generalized myasthenia gravis
BOSTON — Eculizumab significantly reduced disease severity and improved quality of life at 26 weeks in adolescents with refractory generalized myasthenia gravis, according to a presenter at the American Academy of Neurology annual meeting.
Interneuron cell therapy results in up to 94% seizure reduction in focal epilepsy
BOSTON — Implantation of GABAergic interneuron cells in two patients with drug-resistant focal epilepsy resulted in significant seizure reduction, according to preliminary data presented at the American Academy of Neurology annual meeting.
Increases in myelin, white matter reported at 6 months with Canavan disease gene therapy
Myrtelle Inc. has reported promising 6-month trial data for a recombinant adeno-associated virus vector-based investigational gene therapy for Canavan disease.
FDA approves spinal cord stimulation system for chronic pain
The FDA has approved Prospera, a spinal cord stimulation system to treat those with chronic intractable pain in the upper body and limbs.
FDA clears implantable nerve stimulation system
The FDA has granted clearance to Neuspera Medical for its novel implantable system to treat chronic peripheral nerve pain.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read